Senolytic Drugs Market to Grow with Impressive CAGR During the Forecast Period
Global Senolytic Drugs Market is
driven by advancing pharmaceutical industry in the forecast period, 2023-2027.
According to TechSci Research report, “Senolytic
Drugs Market - Global Industry Size, Share, Trends, Opportunity and
Forecast, 2017-2027”, the global senolytic drugs market has a
potential to project an impressive CAGR toward forces growth in the period, 2023-2027,
on the account of increasing demand for anti-aging drugs. Rapidly advancing
healthcare sector and expanding pharmaceutical industry is further responsible
for the growth of the global senolytic drugs market in the upcoming five years.
Surge in the demand for the advanced pharmaceutical and therapeutics in
the major economies is further anticipated to support the growth of the global
senolytic drugs market in the next five years. Multiple market players have
invested in research and rapidly increasing their financial supports to the
research institutes and academic center dedicated toward designing anti-aging
drugs and senolytic drugs thus substantiating the growth of the global
senolytic drugs market in the future five years.
Increasing instances of chronic diseases like cardiovascular diseases,
neurodegenerative diseases, chronic obtrusive pulmonary diseases (COPD), etc.
is also raising the demand for the senolytic drugs thus aiding the growth of
the global senolytic drugs market in the forecast years, until 2027. Rapidly
growing cases of geriatric population suffering from high blood pressure,
diabetes, Alzheimer
disease and Parkinson disease, are related to the growing age among humans.
With increasing geriatric population of the world
that may exceed 1 billion counts in next 30 years is also one of the major
reasons behind futuristic growth of the global senolytic drugs market in the
upcoming five years.
Although, stringent rules and regulations regarding
FDA approvals and clinical trials on the developing senolytic drugs may put
mild restraint on the growth of the global senolytic drugs market in the
future.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Senolytic Drugs Market"
https://www.techsciresearch.com/report/senolytic-drugs-market/8205.html
The global senolytic drugs market segmentation is based on type,
application, distribution channel, regional distribution, and competitive
landscape. Based on type, the market is fragmented into FOXO4-related peptides,
bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib
& Quercetin, and others. Dasatinib,
Quercetin, Fisetin and Navitoclax are some of the primarily discovered
senolytic drugs through hypothesis.
Pre-clinical functions of the of the senolytic drugs were designed to be
preventive toward cancers, and cardiovascular, neuropsychiatric, liver, kidney,
musculoskeletal, lung, eye, hematological, metabolic and skin disorders. Also,
clinical trials of these drugs against diabetes, idiopathic pulmonary fibrosis,
Alzheimer’s disease, COVID-19, osteoarthritis, osteoporosis, eye disease, etc. are
continued. The studies are still being conducted and commercialization of these
drugs have still not started.
Market segmentation based on application, bifurcates into longevity,
senescence inhibition, cardiovascular diseases, neural degenerative diseases,
and others. Longevity is anticipated to hold the largest revenue shares of the
market and dominate the market segment in the upcoming five years on the
account of increasing demand for the pharmaceutical products that can aid
healthy lifespan in humans. Rapidly increasing geriatric population of the
world is further driving the growth of the global senolytic drugs market in the
next five years.
Senescence inhibition is the process of killing the aged cells that are
not dividing and accumulating in a location forming tumorous lump. Usually,
senescence in cells is a stress response mechanism induced by different type of
bodily responses like telomere attrition, DNA damage, and oncogenic mutations,
etc. Available therapeutics target such senescent cells act on specific killing
of these cells by senolytic process, specific inhibition of the secretory
phenotype, and improving removal of senescent cells by immune system.
Some of the market players, dominating the global senolytic drugs market
are:
·
AgeX Therapeutics, Inc.
·
Cleara Biotech
·
Eternans Ltd.
·
FoxBio Inc
·
Numeric Biotech
·
T.A. Sciences, Inc.
·
Recursion Pharmaceuticals, Inc.
The existing market players
are highly invested in research and product development along with viable
service provisions for the consumers. New market entrants may follow similar
strategies along with merger and acquisition methods for future brand
establishment.
Download Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=8205
Customers can also request for 10%
free customization on this report.
“North America is anticipated to hold the largest revenue shares
of the market and dominate the regional analysis in the upcoming five years on
the account of expanding healthcare industry in the region. In the major
economies like the United States, and Canada, healthcare sector is booming on
the basis of increasing research and advancement in the pharmaceutical sector
in the countries along with the increasing investment in the pharmaceutical
designing, production and further research over senescent cells. Moreover,
government aid along with the FDA approvals for the senolytic drugs is further
anticipated to aid the growth of the global senolytic drugs market in the next
five years,” said Mr. Karan Chechi, Research Director with TechSci Research, a
research based global management consulting firm.
“Senolytic
Drugs Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027
Segmented
By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase
Inhibitors, Navitoclax, Dasatinib & Quercetin, Others), By Application
(Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative
Diseases, Others), By Distribution Channel (Retail Pharmacies, Hospital
Pharmacies, Online Pharmacies), By Region”, has evaluated the future growth potential of global senolytic
drugs and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in global senolytic drugs
market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/